• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻二酚对9-四氢大麻酚作用的影响。

Influence of cannabidiol on delta-9-tetrahydrocannabinol effects.

作者信息

Dalton W S, Martz R, Lemberger L, Rodda B E, Forney R B

出版信息

Clin Pharmacol Ther. 1976 Mar;19(3):300-9. doi: 10.1002/cpt1976193300.

DOI:10.1002/cpt1976193300
PMID:770048
Abstract

Experiments investigating the possible interaction of tetrahydrocannabinol (THC) and cannabidiol (CBD), two major components of marihuana, were conducted under controlled laboratory conditions in a double-blind manner. In one study, 15 male volunteers were given placebo or 25 mug/kg of THC together with either placebo or 150 mug/kg of CBD by inhalation of the smoke of a single cigarette. All four treatments were assigned to each subject according to a series of Latin-square designs. CBD significantly attenuated the subjective euphoria of THC. Psychomotor impairment due to THC was not significantly altered by the simultaneous administration of CBD, but a trend indicating a decrease in THC-like effects was observed after the combination. When administered alone CBD was inactive for all the parameters measured. In a second study, 8 male subjects were given CBD (0 or 150 mug/kg) by smoke inhalation 30 min before THC (0 or 25 mug/kg) in a second cigarette. In contrast to the simultaneous administration of both drugs, CBD pretreatment did not alter the effects of THC on the parameters observed.

摘要

在可控的实验室条件下,以双盲方式开展了研究大麻两种主要成分四氢大麻酚(THC)和大麻二酚(CBD)可能的相互作用的实验。在一项研究中,15名男性志愿者通过吸入单支香烟烟雾,被给予安慰剂或25微克/千克的THC,同时还被给予安慰剂或150微克/千克的CBD。根据一系列拉丁方设计,将所有四种处理分配给每个受试者。CBD显著减弱了THC引起的主观欣快感。同时给予CBD时,THC导致的精神运动功能损害没有显著改变,但联合使用后观察到一种表明THC样效应降低的趋势。单独给予CBD时,对于所测量的所有参数均无活性。在第二项研究中,8名男性受试者在吸第二支含THC(0或25微克/千克)的香烟前30分钟,通过吸入烟雾给予CBD(0或150微克/千克)。与同时给予两种药物不同,CBD预处理并未改变THC对所观察参数的影响。

相似文献

1
Influence of cannabidiol on delta-9-tetrahydrocannabinol effects.大麻二酚对9-四氢大麻酚作用的影响。
Clin Pharmacol Ther. 1976 Mar;19(3):300-9. doi: 10.1002/cpt1976193300.
2
A randomised controlled trial of vaporised Δ-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.一项随机对照试验研究了在频繁和不频繁使用大麻的人群中单独使用和联合使用蒸气化 Δ-四氢大麻酚和大麻二酚的效果:急性中毒效应。
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):17-35. doi: 10.1007/s00406-019-00978-2. Epub 2019 Jan 19.
3
Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol.人源中δ-9-四氢大麻酚的相互作用。II. 大麻酚和大麻二酚。
Clin Pharmacol Ther. 1975 Jul;18(1):80-3. doi: 10.1002/cpt197518180.
4
Absence of interaction between delta9-tetrahydrocannabinol (delta-THC) and cannabidiol (CBD) in aggression, muscle control and body temperature experiments in mice.在小鼠的攻击行为、肌肉控制和体温实验中,δ9-四氢大麻酚(δ-THC)与大麻二酚(CBD)之间不存在相互作用。
Psychopharmacologia. 1975;41(2):169-74. doi: 10.1007/BF00421075.
5
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.δ-9-四氢大麻酚、大麻二酚及其组合对面部表情识别的急性影响:一项针对大麻使用者的随机、双盲、安慰剂对照研究。
Eur Neuropsychopharmacol. 2015 Mar;25(3):325-34. doi: 10.1016/j.euroneuro.2014.11.014. Epub 2014 Dec 5.
6
Effects of marihuana-dextroamphetamine combination.
Clin Pharmacol Ther. 1976 Sep;20(3):350-8. doi: 10.1002/cpt1976203350.
7
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.口服大麻二酚不会改变吸食大麻的主观、强化或心血管效应。
Neuropsychopharmacology. 2016 Jul;41(8):1974-82. doi: 10.1038/npp.2015.367. Epub 2015 Dec 28.
8
Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study.大麻提取物致精神模拟效应中,大麻二酚和 δ-9-四氢大麻酚作用相反:一项自然主义对照研究。
J Clin Psychopharmacol. 2021;41(5):561-570. doi: 10.1097/JCP.0000000000001457.
9
Effects of marihuana combined with secobarbital.
Clin Pharmacol Ther. 1975 Sep;18(3):298-304. doi: 10.1002/cpt1975183298.
10
Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.大麻二酚和 Δ9-四氢大麻酚对驾驶性能的影响:一项随机临床试验。
JAMA. 2020 Dec 1;324(21):2177-2186. doi: 10.1001/jama.2020.21218.

引用本文的文献

1
Quantifying Heart Rate Changes After Delta-9-Tetrahydrocannabinol Administration Using a PBPK-PD Model in Healthy Adults.使用PBPK-PD模型对健康成年人服用Δ-9-四氢大麻酚后的心率变化进行量化。
Pharmaceutics. 2025 Feb 12;17(2):237. doi: 10.3390/pharmaceutics17020237.
2
The effects of standardized cannabis products in healthy volunteers and patients: a systematic literature review.标准化大麻产品对健康志愿者和患者的影响:一项系统的文献综述。
Front Pharmacol. 2024 Oct 17;15:1411631. doi: 10.3389/fphar.2024.1411631. eCollection 2024.
3
Cannabidiol and Delta-9-Tetrahydrocannabinol Interactions in Male and Female Rats With Persistent Inflammatory Pain.
大麻二酚与Δ9-四氢大麻酚在慢性炎性痛雄性和雌性大鼠体内的相互作用
J Pain. 2023 Jan;24(1):98-111. doi: 10.1016/j.jpain.2022.09.002. Epub 2022 Sep 16.
4
Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot.效力以及治疗性四氢大麻酚(THC)与大麻二酚(CBD)的比例:美国大麻市场过热。
Front Pharmacol. 2022 Jun 6;13:921493. doi: 10.3389/fphar.2022.921493. eCollection 2022.
5
Roles of the Cannabinoid System in the Basal Ganglia in Parkinson's Disease.大麻素系统在帕金森病基底节中的作用。
Front Cell Neurosci. 2022 Feb 21;16:832854. doi: 10.3389/fncel.2022.832854. eCollection 2022.
6
A Phase 2 Randomised Clinical Trial Assessing the Tolerability of Two Different Ratios of Medicinal Cannabis in Patients With High Grade Gliomas.一项评估两种不同比例药用大麻对高级别胶质瘤患者耐受性的2期随机临床试验。
Front Oncol. 2021 May 21;11:649555. doi: 10.3389/fonc.2021.649555. eCollection 2021.
7
Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review.大麻二酚对Δ-9-四氢大麻酚所致精神病性症状、精神分裂症及大麻使用障碍的疗效:一项叙述性综述
J Clin Med. 2021 Mar 22;10(6):1303. doi: 10.3390/jcm10061303.
8
Advancing the science on cannabis concentrates and behavioural health.推进大麻浓缩物与行为健康相关科学研究。
Drug Alcohol Rev. 2021 Sep;40(6):900-913. doi: 10.1111/dar.13281. Epub 2021 Mar 30.
9
Clinical Trials of Cannabidiol for Substance Use Disorders: Outcome Measures, Surrogate Endpoints, and Biomarkers.大麻二酚用于物质使用障碍的临床试验:结局指标、替代终点和生物标志物
Front Psychiatry. 2021 Feb 22;12:565617. doi: 10.3389/fpsyt.2021.565617. eCollection 2021.
10
Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson's Disease.大麻二酚作为一种治疗靶点:其在帕金森病中神经保护和神经调节功能的证据
Front Pharmacol. 2020 Dec 15;11:595635. doi: 10.3389/fphar.2020.595635. eCollection 2020.